Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: Inhibitory effect of metformin

Diabetes

Volumn 54, Issue 7, 2005, Pages 2227-2234

  Li, Ling ^a   Mamputu, Jean Claude ^a   Wiernsperger, Nicolas ^b   Renier, Geneviève ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ALPHA TOCOPHEROL; APOCYNIN; BAY 117085; DIPHENYLIODONIUM SALT; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; RECOMBINANT LEPTIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THENOYLTRIFLUOROACETONE; UNCLASSIFIED DRUG;

ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

AORTA; CELL DIVISION; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; LEPTIN; MATRIX METALLOPROTEINASE 2; METFORMIN; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; PROTEIN KINASE C;

EID: 21344456357     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.7.2227     Document Type: Article

References (62)

1. Abate N: Obesity and cardiovascular disease: pathogenic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14:154-174, 2000
2. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
3. Couillard C, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ, Despres JP: Leptinemia is not a risk factor for ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Diabetes Care 21:782-786, 1998
4. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L, Perseghin G: Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 26:2883-2889, 2003
5. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M: Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276:25096-25100, 2001
6. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, Cho SY, Kim HS: Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33:95-102, 2001
7. Oda A, Taniguchi T, Yokoyama M: Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 47:141-150, 2001
8. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL: Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88:954-960, 2001
9. Nakata M, Yada T, Soejima N, Maruyama I: Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48:426-429, 1999
10. Santos-Alvarez J, Goberna R, Sanchez-Margalet V: Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194:6-11, 1999
11. Faggioni R, Feingold KR, Grunfeld C: Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 15:2565-2571, 2001
12. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897-901, 1998
13. Kang SM, Kwon HM, Hong BK, Kim D, Kim LI, Choi EY, Jang Y, Kim HS, Kim MS, Kwon HC: Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization. Yonsei Med J 41:68-75, 2000
14. Yen TT, Allan JA, Pearson DV, Schinitsky MR: Dissociation of obesity, hypercholesterolemia, and diabetes from atherosclerosis in ob/ob mice. Experientia 33:995-996, 1977
15. Hasty AH, Shimano H, Osuga J, Namatame I, Takahashi A, Yahagi N, Perrey S, Iizuka Y, Tamura Y, Amemiya-Kudo M, Yoshikawa T, Okazaki H, Ohashi K, Harada K, Matsuzaka T, Sone H, Gotoda T, Nagai R, Ishibashi S, Yamada N: Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276:37402-37408, 2001
16. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
17. Howlett HCS, Bailey CJ: A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Sci 20:489-503, 1999
18. Wiensperger NF: Metformin: intrinsic vasculoprotective properties. Diabetes Tech Therap 2:259-272, 2000
19. Mamputu JC, Wiernsperger N, Renier G: Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation. Br J Diabetes Vasc Dis 3:302-310, 2003
20. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF: NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 40:755-762, 2002
21. Holland PC, Clark MG, Bloxham DP, Lardy HA: Mechanism of action of the hypoglycemic agent diphenyleneiodonium. J Biol Chem 248:6050-6056, 1973
22. Kimura C, Oike M, Ito Y: Hypoxia-induced alterations in Ca(2+) mobilization in brain microvascular endothelial cells. Am J Physiol Heart Circ Physiol 279:H2310-H2318, 2000
23. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, et al: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781, 1991
24. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689, 1995
25. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME: Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096-21103, 1997
26. Berridge MV, Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474-482, 1993
27. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 221:91-103, 1993
28. Yano T, Taura C, Shibata M, Hirono Y, Ando S, Kusubata M, Takahashi T, Inagaki M: A monoclonal antibody to the phosphorylated form of glial fibrillary acidic protein: application to a non-radioactive method for measuring protein kinase activities. Biochem. Biophys Res Commun 175:1144-1151, 1991
29. Versteeg HH, Nyhuis E, van den Brink GR, Evertzen M, Pynaert GN, van Deventer SJ, Coffer PJ, Peppelenbosch MP: A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem J 350:717-722, 2000
30. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M, Remade J: Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acid Res 29:E21-E25, 2001
31. Mamputu JC, Wiernsperger NF, Renier G: Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab 29:71-76, 2003
32. Marquié G: Metformin action on lipid metabolism in lesions of experimental aortic atherosclerosis of rabbits. Atherosclerosis 47:7-17, 1983
33. Marquié G: Comparative effects of metformin and phenformin on the progression and regression of cholesterol induced atherosclerosis in rabbits. Paroi Arterielle 5:209-218, 1973
34. Bunting CE, Koschinsky T, Rütter R, Gries FA: Metformin inhibits the growth of human vascular cells: a new potentially antiatherogenic drug effect (Abstract). Diabetologia 29:523A, 1986
35. Weber G, Catapano A, Ghiselli G, Sirtori CR: Experimental studies on the antiatherosclerotic effect of metformin. In Proceedings of the International Conference on Atherosclerosis. Carlson LA, Paoletti R, Sirtori CR, Weber G, Eds. New York, Raven Press, 1978, p. 318-325
36. Schäfer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, Konstantinides S: Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thomb Vasc Biol 24:112-117, 2004
37. Reilly MP, Iqbal N, Schutta M, Wolfe ML, Scally M, Localio AR, Rader DJ, Kimmel SE: Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 89:3872-3878, 2004
38. Beltowski J, Wojccicka G, Jamroz A: Leptin decreases plasma paraoxonase 1 (PON 1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 170:21-29, 2003
39. Bouloumie A, Marumo T, Lafontan M, Busse R: Leptin induces oxidative stress in human endothelial cells. FASEB J 13:1231-1238, 1999
40. Maingrette F, Renier G: Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes 52:2121-2128, 2003
41. Lee HS, Son SM, Kim YK, Hong KW, Kim CD: NAD(P)H oxidase participates in the signaling events in high-glucose-induced proliferation of vascular smooth muscle cells. Life Sci 72:2719-2730, 2003
42. Gorlach A, Kietzmann T, Hess J: Redox signaling through NADPH oxidases: involvement in vascular proliferation and coagulation. Ann N Y Acad Sci 973:505-507, 2002
43. Pavlovic D, Kocic R, Kocic G, Jevtovic T, Radenkovic S, Mikic D, Stojanovic M, Djordjevic PB: Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab 2:251-256, 2000
44. Bonnefont-Rousselot D, Raji B, Walrand S, Gardes-Albert M, Jore D, Legrand A, Peynet J, Vasson MP: An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 52:586-589, 2003
45. Gargiulo P, Caccese D, Pignatelli P, Brufani C, De Vito F, Marino R, Lauro R, Violi F, Di Mario U, Sanguigni V: Metformin decreases platelet superoxide anion production in diabetic patients. Diabetes Metab Res Rev 18:156-159, 2002
46. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acids stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939-1945, 2000
47. Lu G, Greene EL, Nagai T, Egan BM: Reactive oxygen species are critical in the oleic-acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 32:1003-1010, 1998
48. Hattori Y, Kakishita H, Akimoto K, Matsumura M, Kasai K: Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C. Biochem Biophys Res Commun 281:891-896, 2001
49. Bouloumie A, Drexler HCA, Lafontan M, Busse R: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059-1066, 1998
50. Goetze S, Bungenstock A, Czupalla C, Eilers F, Stawowy P, Kintscher U, Spencer-Hänsch C, Graf K, Nürnberg B, Law RE, Fleck E, Gräfe M: Leptin induces endothelial cell migration through Akt which is inhibited by PPARγ ligands. Hypertension 40:748-754, 2002
51. Tasinato A, Boscoboinik D, Bartoli GM, Maroni P, Azzi A: d-alpha tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci U S A 92:12190-12194, 1995
52. Azzi A, Boscoboinik D, Clement S, Marilley D, Ozer NK, Ricciarelli R, Tasinato A: Alpha-tocopherol as a modulator of smooth muscle cell proliferation. Prostaglandins Leukot Essent Fatty Acids 57:507-514, 1997
53. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174, 2001
54. Ido Y, Carling D, Ruderman N: Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51:159-167, 2002
55. Muoio DM, Seefeld K, Witters LA, Coleman RA: AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338:783-791, 1999
56. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R: Hyperglycemia- induced activation of transcription factor κB in vascular smooth muscle cells. Diabetes 48:855-864, 1999
57. Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H: Regulation of vascular smooth muscle cell proliferation by nuclear factor-κ and its inhibitor, I-κB. J Biol Chem 275:883-889, 2000
58. Cacicedo JM, Yagihashi N, Keaney JF, Ruderman NB, Ido Y: AMPK inhibits fatty acid-induced increases in NF-κB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Comm 324:1204-1209, 2004
59. Newby AC, Southgate KM, Davies M: Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol 89:59-70, 1994
60. Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, Struber M, Haverich A, Bavendiek U, Drexler H, Schieffer B: Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem. Biophys Res Commun 328:183-188, 2005
61. Hussain S, Assender JW, Bond M, Wong L-F, Murphy D, Newby AC: Activation of protein kinase C zeta is essential for cytokine-induced metalloproteinase-1, -3, and -9 secretion from rabbit smooth muscle cells and inhibits proliferation. J Biol Chem 277:27345-27352, 2002
62. Bond M, Fabunmi RP, Baker AH, Newby AC: Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 435:29-34, 1998